Europe Nuclear Medicine Market Size, Share, Opportunities, And Trends By Technology (PET, SPECT), By Application (Central Nervous System, Endocrine, Skeletal, Gastrointestinal, Genitourinary, Pulmonary), By End User(Hospitals, Diagnostic Centres, Research Institutions) - Forecasts From 2019 To 2024

Published:  Mar 2021 Report Code: KSI061610989 Pages: 114

The European Nuclear medicine Market was valued at US$X.XX billion in 2016 and is projected to expand at a CAGR of XX.XX% over the forecast period to reach US$X.XX billion by 2022. This research study examines the nuclear medicine market on the basis of various segments. Major drivers, restraints, and opportunities have been mentioned to provide an exhaustive picture of the market. Furthermore, the current market trends related to the demand, supply, and sales, in addition to the recent developments, have been provided in this report.  The report also analyzes key players in the nuclear medicine market. The report provides comprehensive forecast up to the period 2022 for various key segments, with 2016 as base year.        

The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical segments. Moreover, the research study analyzes the overall regulatory framework of the European nuclear medicine market, offering stakeholders a better understanding of the key factors affecting the overall market environment.

The first step towards determining the nuclear medicine market size involves identifying key players and the revenue contribution of the overall business or relevant segment aligned to the study in consideration through extensive secondary research. This also includes various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others. Both bottom-up and top down approaches are utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the nuclear medicine value chain, who are C-Level Executives, Directors, and Managers among others across key enterprises operating as manufacturers, suppliers, and distributors. The last phase is providing intelligence in the form of presentation, charts, graphics and other different formats helping the clients in faster and efficient understanding of the market. Under this phase complete market engineering is involved which includes analyzing the gathered data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Segments covered under the nuclear medicine market report are as below:

By Applications

SPECT Market

PET Market

 

 

By Procedures

Central Nervous System

Endocrine

Skeletal

Gastrointestinal

Genito-urinary

Pulmonary

 

 

By End-User Industry

Hospitals

Diagnostic centers

Research Institutes

 

 

By Geography

European

UK

Germany

France

Spain

Italy

Others

 

 

 

Key industry players profiled as part of this section are BRACCO PHARMA, Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Fujifilm Holdings Corporation, GE Healthcare (Subsidiary of General Electric Company), Nordion, Inc., and Taiyo Nippon Sanso Corporation among few others.  

 

 The report’s target audience is as below:

Manufacturers

Suppliers

Distributors

Service Providers

Government Agencies

Research Organizations

Consultants

 

 

 

1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. Key Findings of the Study
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. European Nuclear Medicine Market Forecast by Applications (US$ Billion)
5.1. Introduction
5.2. SPECT Market
5.3. PET Market
6. European Nuclear Medicine Market Forecast by Procedures (US$ Billion)
6.1. Introduction
6.2. Central Nervous System
6.3. Endocrine
6.4. Skeletal
6.5. Gastrointestinal
6.6. Genito-urinary
6.7. Pulmonary
7. European Nuclear Medicine Market Forecast by End-User Industry (US$ Billion)
7.1. Introduction
7.2. Hospitals
7.3. Diagnostic centers
7.4. Research Institutes
8. European Nuclear Medicine Market Forecast by Geography (US$ Billion)
8.1. Introduction
8.2. European
8.2.1. UK
8.2.2. Germany
8.2.3. France
8.2.4. Spain
8.2.5. Italy
8.2.6. Others
9. Competitive Intelligence
9.1. Strategies of Key Players
9.2. Recent Investments and Deals
10. Company Profiles
10.1. Introduction
10.2. Bracco
10.2.1. Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Key Developments 
10.3. Cambridge Isotope Laboratories, Inc. 
10.3.1. Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Key Developments 
10.4. Cardinal Health 
10.4.1. Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Key Developments 
10.5. Fujifilm Holdings Corporation
10.5.1. Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Key Developments 
10.6. GE Healthcare (Subsidiary of General Electric Company) 
10.6.1. Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Key Developments 
10.7. Nordion, Inc. 
10.7.1. Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Key Developments 
10.8. Taiyo Nippon Sanso Corporation
10.8.1. Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Key Developments 
10.9. Lantheus Medical Imaging, Inc.
10.9.1. Overview
10.9.2. Financials
10.9.3. Products and Services
10.9.4. Key Developments 
10.10. Koninklijke Philips N.V
10.10.1. Overview
10.10.2. Financials
10.10.3. Products and Services
10.10.4. Key Developments 
10.11. Digirad Corporation
10.11.1. Overview
10.11.2. Financials
10.11.3. Products and Services
10.11.4. Key Developments 
List of Tables
List of Figures

Bracco
Cambridge Isotope Laboratories, Inc. 
Cardinal Health 
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary of General Electric Company)  
Nordion, Inc. 
Taiyo Nippon Sanso Corporation 
Lantheus Medical Imaging, Inc.
Koninklijke Philips N.V
Digirad Corporation

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us